Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation
Authors
Keywords
Nilotinib, Skeletal muscle, Differentiation, Myoblasts, Proliferation, Tyrosine kinase inhibitors, p38 MAPK, ERK1/2, AKT
Journal
Skeletal Muscle
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-20
DOI
10.1186/s13395-018-0150-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development
- (2017) Pedro Vallecillo-García et al. Nature Communications
- Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis
- (2016) Osvaldo Contreras et al. CELL AND TISSUE RESEARCH
- Dexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells
- (2016) Luca Massaccesi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Intronic polyadenylation of PDGFRα in resident stem cells attenuates muscle fibrosis
- (2016) Alisa A. Mueller et al. NATURE
- Pharmacological blockage of fibro/adipogenic progenitor expansion and suppression of regenerative fibrogenesis is associated with impaired skeletal muscle regeneration
- (2016) Daniela Fiore et al. Stem Cell Research
- Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling
- (2016) Antonina Frolov et al. Scientific Reports
- Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
- (2015) J. W. McGreevy et al. Disease Models & Mechanisms
- Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors
- (2015) Dario R Lemos et al. NATURE MEDICINE
- Angiotensins as therapeutic targets beyond heart disease
- (2015) Danielle Gomes Passos-Silva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
- (2014) Sue C. Bodine et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Muscle wasting: an overview of recent developments in basic research
- (2014) Sandra Palus et al. Journal of Cachexia Sarcopenia and Muscle
- Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle
- (2014) Akiyoshi Uezumi et al. Frontiers in Physiology
- Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling
- (2013) María José Acuña et al. HUMAN MOLECULAR GENETICS
- NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
- (2013) Wei A. He et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
- (2013) Rebecca J. Fairclough et al. NATURE REVIEWS GENETICS
- Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors
- (2013) Takahito Ito et al. NEUROMUSCULAR DISORDERS
- Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage
- (2012) F. Relaix et al. DEVELOPMENT
- Bleach gel: A simple agarose gel for analyzing RNA quality
- (2012) Patrick S. Aranda et al. ELECTROPHORESIS
- Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib
- (2012) Giovanni Caocci et al. LEUKEMIA RESEARCH
- Building Muscle: Molecular Regulation of Myogenesis
- (2012) C. F. Bentzinger et al. Cold Spring Harbor Perspectives in Biology
- The skeletal effects of the tyrosine kinase inhibitor nilotinib
- (2011) Susannah O'Sullivan et al. BONE
- The tyrosine kinase inhibitor nilotinib inhibits proliferation and osteoblast differentiation of human mesenchymal stromal cells
- (2011) Lizhen Liu et al. BONE
- Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
- (2011) Leisl M. Packer et al. CANCER CELL
- Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration
- (2011) M. M. Murphy et al. DEVELOPMENT
- An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration
- (2011) C. Lepper et al. DEVELOPMENT
- Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle
- (2011) A. Uezumi et al. JOURNAL OF CELL SCIENCE
- Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
- (2011) Yuqing Liu et al. JOURNAL OF HEPATOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice
- (2011) Chin Kook Rhee et al. RESPIRATION
- Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis
- (2011) Mohamed E. Shaker et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis
- (2011) James DR Knight et al. Skeletal Muscle
- Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase
- (2010) Hagop M. Kantarjian et al. CANCER
- Connective tissue fibroblasts and Tcf4 regulate myogenesis
- (2010) S. J. Mathew et al. DEVELOPMENT
- Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle
- (2010) Akiyoshi Uezumi et al. NATURE CELL BIOLOGY
- Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
- (2010) Aaron W. B. Joe et al. NATURE CELL BIOLOGY
- Targeting non-malignant disorders with tyrosine kinase inhibitors
- (2010) Friedrich Grimminger et al. NATURE REVIEWS DRUG DISCOVERY
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted therapies and autophagy: new insights from chronic myeloid leukemia
- (2009) Paolo Salomoni et al. Autophagy
- Imatinib attenuates skeletal muscle dystrophy in mdx mice
- (2009) Ping Huang et al. FASEB JOURNAL
- Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec™)
- (2009) Jessica K. Gordon et al. LEUKEMIA RESEARCH
- Cdo Binds Abl To Promote p38 / Mitogen-Activated Protein Kinase Activity and Myogenic Differentiation
- (2009) G.-U. Bae et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of Muscle Degeneration, Regeneration, and Repair in the Muscular Dystrophies
- (2008) Gregory Q. Wallace et al. Annual Review of Physiology
- Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
- (2008) Alfiya Akhmetshina et al. FASEB JOURNAL
- Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib
- (2008) Oliver Hantschel et al. LEUKEMIA & LYMPHOMA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started